Earnings Report Digest

Abbott Laboratories (ABT), 2025 Q2 earnings digest

1 min · 18 de jul de 2025
Portada del episodio Abbott Laboratories (ABT), 2025 Q2 earnings digest

Descripción

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. 📊✨ For more details, check valueverge.com/ABT.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Earnings Report Digest!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

469 episodios